(Q78077041)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11999465%20AND%20SRC:MED&resulttype=core&format=json

10 December 2019

title

Correlation of initial PSA level and biopsy features with PSA-doubling time in early stage prostate cancers in Japanese men (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11999465%20AND%20SRC:MED&resulttype=core&format=json

10 December 2019

1 reference

Yoshiyuki Kakehi

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11999465%20AND%20SRC:MED&resulttype=core&format=json

10 December 2019

Toshiyuki Kamoto

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11999465%20AND%20SRC:MED&resulttype=core&format=json

10 December 2019

Taizo Shiraishi

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11999465%20AND%20SRC:MED&resulttype=core&format=json

10 December 2019

Tetsuro Kato

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11999465%20AND%20SRC:MED&resulttype=core&format=json

10 December 2019

Ken-ichi Tobisu

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11999465%20AND%20SRC:MED&resulttype=core&format=json

10 December 2019

Koichiro Akakura

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11999465%20AND%20SRC:MED&resulttype=core&format=json

10 December 2019

Shin Egawa

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11999465%20AND%20SRC:MED&resulttype=core&format=json

10 December 2019

Osamu Maeda

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11999465%20AND%20SRC:MED&resulttype=core&format=json

10 December 2019

Yoshiteru Sumiyoshi

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11999465%20AND%20SRC:MED&resulttype=core&format=json

10 December 2019

Yoichi Arai

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11999465%20AND%20SRC:MED&resulttype=core&format=json

10 December 2019

Osamu Ogawa

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11999465%20AND%20SRC:MED&resulttype=core&format=json

10 December 2019

publication date

1 January 2002

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11999465%20AND%20SRC:MED&resulttype=core&format=json

10 December 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11999465%20AND%20SRC:MED&resulttype=core&format=json

10 December 2019

volume

41

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11999465%20AND%20SRC:MED&resulttype=core&format=json

10 December 2019

page(s)

47-53

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11999465%20AND%20SRC:MED&resulttype=core&format=json

10 December 2019

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11999465%20AND%20SRC:MED&resulttype=core&format=json

Cancer incidence in Japan in 1991: estimates based on data from population-based cancer registries. The Research Group for Population-based Cancer Registration in Japan (5-3)

10 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0302-2838%2801%2900020-3

7 January 2021

Estimates of the worldwide incidence of 25 major cancers in 1990.

1 reference

https://api.crossref.org/works/10.1016%2FS0302-2838%2801%2900020-3

7 January 2021

Trends in frequency of latent prostate carcinoma in Japan from 1965-1979 to 1982-1986

1 reference

https://api.crossref.org/works/10.1016%2FS0302-2838%2801%2900020-3

7 January 2021

Preoperative predictors for organ-confined disease in Japanese patients with stage T1c prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0302-2838%2801%2900020-3

7 January 2021

The pathological features and prognosis of prostate cancer detectable with current diagnostic tests

1 reference

https://api.crossref.org/works/10.1016%2FS0302-2838%2801%2900020-3

7 January 2021

Impalpable invisible stage T1c prostate cancer: characteristics and clinical relevance in 100 radical prostatectomy specimens--a different view

1 reference

https://api.crossref.org/works/10.1016%2FS0302-2838%2801%2900020-3

7 January 2021

Linear regressive analysis using prostate-specific antigen doubling time for predicting tumor biology and clinical outcome in prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0302-2838%2801%2900020-3

7 January 2021

Evaluation of serum prostate-specific antigen velocity after radical prostatectomy to distinguish local recurrence from distant metastases

1 reference

https://api.crossref.org/works/10.1016%2FS0302-2838%2801%2900020-3

7 January 2021

Proliferative Activity of Benign Human Prostate, Prostatic Adenocarcinoma and Seminal Vesicle Evaluated by Thymidine Labeling

1 reference

https://api.crossref.org/works/10.1016%2FS0302-2838%2801%2900020-3

7 January 2021

Prostate specific antigen in the diagnosis and treatment of adenocarcinoma of the prostate. I. Untreated patients

1 reference

https://api.crossref.org/works/10.1016%2FS0302-2838%2801%2900020-3

7 January 2021

Longitudinal evaluation of prostate-specific antigen levels in men with and without prostate disease

1 reference

https://api.crossref.org/works/10.1016%2FS0302-2838%2801%2900020-3

7 January 2021

Observations on the doubling time of prostate cancer. The use of serial prostate-specific antigen in patients with untreated disease as a measure of increasing cancer volume

1 reference

https://api.crossref.org/works/10.1016%2FS0302-2838%2801%2900020-3

7 January 2021

Watchful waiting or watchful progression?: Prostate specific antigen doubling times and clinical behavior in patients with early untreated prostate carcinoma.

1 reference

https://api.crossref.org/works/10.1016%2FS0302-2838%2801%2900020-3

7 January 2021

Prediction of prognosis for prostatic adenocarcinoma by combined histological grading and clinical staging

1 reference

https://api.crossref.org/works/10.1016%2FS0302-2838%2801%2900020-3

7 January 2021

Therapeutic dilemmas in prostate cancer: justification for watchful waiting

1 reference

https://api.crossref.org/works/10.1016%2FS0302-2838%2801%2900020-3

7 January 2021

Results of conservative management of clinically localized prostate cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS0302-2838%2801%2900020-3

7 January 2021

Long-term survival in a Swedish population-based cohort of men with prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0302-2838%2801%2900020-3

7 January 2021

Competing risk analysis of men aged 55 to 74 years at diagnosis managed conservatively for clinically localized prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0302-2838%2801%2900020-3

7 January 2021

Prostate specific antigen velocity as a measure of the natural history of prostate cancer: defining a 'rapid riser' subset

1 reference

https://api.crossref.org/works/10.1016%2FS0302-2838%2801%2900020-3

7 January 2021

Prostate carcinoma incidence and patient mortality: the effects of screening and early detection.

1 reference

https://api.crossref.org/works/10.1016%2FS0302-2838%2801%2900020-3

7 January 2021

10.1016/S0302-2838(01)00020-3

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11999465%20AND%20SRC:MED&resulttype=core&format=json

10 December 2019

1 reference